TheEdgeResearch
Home / Stocks / GWIN

Glorywin Entertainment Group, Inc. (GWIN)

OTC Healthcare Biotechnology
$0.66 ▲ +0.00%
Market Cap
$234.7M
Sector
Healthcare
Industry
Biotechnology
Beta
-6.94
52-Wk Range
0.176-3.91
CEO
Sorphea Rath
Country
US
Currency
USD

Glorywin Entertainment Group, Inc. operates in the Biotechnology industry of the Healthcare sector, headquartered in Denton, TX, US. The stock last traded at $0.66, up 0.00% on the session, giving a market capitalisation of $234.7M. On trailing twelve-month figures it carries a trailing P/E of -24605.07, a net margin of 0.0%. Its beta of -6.94 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
-24605.07
Price / Sales
0.00
Price / Book
0.00
EV / EBITDA
-24605.07
Gross margin
0.0%
Operating margin
0.0%
Net margin
0.0%
Return on equity
—
Debt / equity
0.00
Current ratio
0.00
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
0
IPO date
2013-12-04
Headquarters
Denton, TX, US
About Glorywin Entertainment Group, Inc.

Glorywin Entertainment Group, Inc. is working on 3D bioprinting technology research and development, and anti-cancer drug research and development. The company was incorporated in 2010 and is based in Denton, Texas.

Comparable companies

Glorywin Entertainment Group, Inc. is most often compared with the following Healthcare names:

AGPUBCCOYBDTXBLSMCLGNCSBRGLSIIPSCIRONVOR
More research on GWIN
GWIN technical analysis GWIN TheEdge Score Compare against peers
Open full interactive analysis & DCF →